ELAN · Healthcare · $11.2B
$21.80-2.64%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 61 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“매출 성장률 8%(전 분기와 비슷한 수준)이지만 내용이 질적으로 강해졌어요 — Zenrelia·Quattro 등 혁신 제품이 견인하며 미국 반려”
In the company's words · 2026 2분기 earnings call